Curis Inc (NASDAQ:CRIS)
| 3.09 Delayed Data As of Jan 21 |  -0.06 / -1.90%Today’s Change | 3.06 Today|||52-Week Range 17.40 | -35.08% Year-to-Date |
Latest CRIS News | Press Releases
No recent news for Curis Inc.
Today’s Trading
| Previous close | 3.15 |
| Today’s open | 3.10 |
| Day’s range | 3.08 - 3.23 |
| Volume | 95,024 |
| Average volume (3 months) | 1,626,713 |
| Market cap | $283.5M |
Data as of 4:00pm ET, 01/21/2022
Growth & Valuation
| Earnings growth (last year) | +36.56% |
| Earnings growth (this year) | +21.86% |
| Earnings growth (next 5 years) | 0.00% |
| Revenue growth (last year) | +8.31% |
| P/E ratio | NM |
| Price/Sales | 36.79 |
| Price/Book | 2.17 |
Competitors
| ---- | ||
| KMDAKamada Ltd | -0.06 | -0.95% |
| DTILPrecision BioScience... | -0.38 | -7.65% |
| SELBSelecta Biosciences ... | -0.10 | -4.00% |
Data as of 4:00pm ET, 01/21/2022
Financials
| Next reporting date | March 10, 2022 |
| EPS forecast (this quarter) | -$0.13 |
| Annual revenue (last year) | $10.8M |
| Annual profit (last year) | -$29.9M |
| Net profit margin | -276.03% |
Profile
Sector Health Technology |
Industry Biotechnology |
No executives to display |
Corporate headquarters Lexington, Massachusetts |
Forecasts
